JSC Olainfarm has received the letter of resignation from Martins Tambaks whereby he steps down from his duties as a member of the Management Board as of 31 July 2019. JSC Olainfarm Management Board continues its work with six board members. M. Tambaks will continue to work at JSC Olainfarm.

“Martins Tambaks is an experienced colleague who has already devoted 6 years to Olainfarm. I understand and respect his decision to resign, and I am grateful to be able to continue our cooperation in achieving common goals,” emphasizes Lauris Macijevskis, Chairman of the Management Board of JSC Olainfarm.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:

Jānis Dubrovskis

Investor Relations Advisor of JSC Olainfarm

Ph.: +371 29178878

janis.dubrovskis@olainfarm.com